The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

is the most common type of multiple sclerosis (MS), making up about 85% of diagnoses. RRMS involves periods known as relapses, during which symptoms worsen, followed by periods of symptom ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

FRIDAY, Dec. 27, 2024 (HealthDay News) -- People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse.

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...